Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACELLULAR PERTUSSIS VACCINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 78 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Granoff, DM
      Assessing efficacy of Haemophilus influenzae type b combination vaccines

      CLINICAL INFECTIOUS DISEASES
    2. Halsey, NA
      Combination vaccines: Defining and addressing current safety concerns

      CLINICAL INFECTIOUS DISEASES
    3. Plotkin, SA
      Vaccines in the 21st century

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    4. Dagan, R; Amir, J; Ashkenazi, S; Hardt, K; Kaufhold, A
      Early responses to nonconjugated polyribosylribitol phosphate challenge asevidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    5. Feldman, S
      Interchangeability of vaccines

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    6. Liese, JG; Stojanov, S; Zink, TH; Froeschle, J; Klepadlo, R; Kronwitter, A; Harzer, E; Jow, S; Belohradsky, BH
      Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six yearsof age

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    7. Plotkin, SA
      Immunologic correlates of protection induced by vaccination

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    8. Siegrist, CA
      Neonatal and early life vaccinology

      VACCINE
    9. De Serres, G; Shadmani, R; Boulianne, N; Duval, B; Rochette, L; Fradet, MD; Halperin, SA
      Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine

      VACCINE
    10. Andre, M; Poirier, B; Bornstein, N; Marmonier, D; El Zaouk, A; Fuchs, F
      Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines

      BIOLOGICALS
    11. Halperin, SA; Smith, B; Russell, M; Scheifele, D; Mills, E; Hasselback, P; Pim, C; Meekison, W; Parker, R; Lavigne, P; Barreto, L
      Adult formulation of a five component acellular pertussis vaccine combinedwith diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    12. Dagan, R; Amir, J; Mijalovsky, A; Kalmanovitch, I; Bar-Yochai, A; Thoelen, S; Safary, A; Ashkenazi, S
      Immunization against hepatitis A in the first year of life: Priming despite the presence of maternal antibody

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    13. Watanabe, M; Nagai, M; Funaishi, K; Endoh, M
      Efficacy of chemically cross-linked antigens for acellular pertussis vaccine

      VACCINE
    14. Watanabe, M; Funaishi, K; Takeo, T; Endoh, M
      Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechins

      VACCINE
    15. Gylca, R; Gylca, V; Benes, O; Melnic, A; Chicu, V; Weisbecker, C; Willems, P; Kaufhold, A
      A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth

      VACCINE
    16. Turnbull, FM; Heath, TC; Jalaludin, BB; Burgess, MA; Ramalho, AC
      A randomized trial of two acellular pertussis vaccines (dTpa and pa) and alicensed diphtheria-tetanus vaccine (Td) in adults

      VACCINE
    17. Minh, NNT; He, QS; Edelman, K; Putto-Laurila, A; Arvilommi, H; Viljanen, MK; Mertsola, J
      Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults

      VACCINE
    18. Halperin, SA; Smith, B; Russell, M; Hasselback, P; Guasparini, R; Skowronski, D; Meekison, W; Parker, R; Lavigne, P; Barreto, L
      An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

      VACCINE
    19. Braun, MM; Mootrey, GT; Salive, ME; Chen, RT; Ellenberg, SS
      Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)

      PEDIATRICS
    20. Decker, AD; Edwards, KM
      Combination vaccines: Problems and promise

      JOURNAL OF PEDIATRICS
    21. Ryan, EJ; McNeela, E; Pizza, M; Rappuoli, R; O'Neill, L; Mills, KHG
      Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: Distinct pro- and anti-inflammatory effects of the nontoxicAB complex and the enzyme activity

      JOURNAL OF IMMUNOLOGY
    22. Halperin, SA; Scheifele, D; Barreto, L; Pim, C; Guasparini, R; Medd, L; Meekison, W; Eastwood, BJ
      Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    23. Tindberg, Y; Blennow, M; Granstrom, M
      A ten year follow-up after immunization with a two component acellular pertussis vaccine

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    24. Pichichero, ME; Voloshen, T; Passador, S
      Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acellular pertussis-Haemophilus influenzaetype b vaccination in infants

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    25. Peters, VB; Mayer, L; Sperber, KE
      Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children

      VIRAL IMMUNOLOGY
    26. Tindberg, Y; Blennow, M; Granstrom, M
      Clinical symptoms and social factors in a cohort of children spontaneouslyclearing Helicobacter pylori infection

      ACTA PAEDIATRICA
    27. Bell, F; Heath, P; MacLennan, J; Shackley, F; Shearstone, N; Diggle, L; Thornton, C; Griffiths, H; Moxon, ER; Finn, A
      Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule

      EUROPEAN JOURNAL OF PEDIATRICS
    28. Habermehl, P; Lignitz, A; Knuf, M; Schmitt, HJ; Slaoui, M; Zepp, F
      Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination

      VACCINE
    29. Rothstein, EP; Anderson, EL; Decker, MD; Poland, GA; Reisinger, KS; Blatter, MM; Jacobson, RM; Mink, CM; Gennevois, D; Izu, AE; Sinangil, F; Langenberg, AGM
      An acellular pertussis vaccine in healthy adults: safety and immunogenicity

      VACCINE
    30. Nakayama, T; Aizawa, C; Kuno-Sakai, H
      A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    31. Meriste, S; Tamm, E; Willems, P; Lutsar, I
      Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    32. Minh, NNT; He, QS; Ramalho, A; Kaufhold, A; Viljanen, MK; Arvilommi, H; Mertsola, J
      Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents

      PEDIATRICS
    33. KRAISINGER M
      UPDATE ON CHILDHOOD IMMUNIZATION

      American journal of health-system pharmacy
    34. LAGOS R; KOTLOFF K; HOFFENBACH A; SANMARTIN O; ABREGO P; URETA AM; PINES E; BLONDEAU C; BAILLEUX F; LEVINE MM
      CLINICAL ACCEPTABILITY AND IMMUNOGENICITY OF A PENTAVALENT PARENTERALCOMBINATION VACCINE CONTAINING DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, INACTIVATED POLIOMYELITIS AND HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE ANTIGENS IN 2, 4 AND 6-MONTH-OLD CHILEAN INFANTS

      The Pediatric infectious disease journal
    35. HALPERIN BA; EASTWOOD BJ; HALPERIN SA
      COMPARISON OF PARENTAL AND HEALTH-CARE PROFESSIONAL PREFERENCES FOR THE ACELLULAR OR WHOLE-CELL PERTUSSIS-VACCINE

      The Pediatric infectious disease journal
    36. Okada, K; Ueda, K; Morokuma, K; Fukushige, J; Miyazaki, C
      Comparison of antibody titers in eleven- to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    37. TORMANS G; VANDOORSLAER E; VANDAMME P; CLARA R; SCHMITT HJ
      ECONOMIC-EVALUATION OF PERTUSSIS PREVENTION BY WHOLE-CELL AND ACELLULAR VACCINE IN GERMANY

      European journal of pediatrics
    38. WAHREN E; BENGTSSON C; BJORKSTEN B; MARK A; GRANSTROM M
      CAPTURE EIA FOR DETERMINATION OF IGE TO DIPHTHERIA AND TETANUS TOXINSIN COMPARISON TO RIA

      Vaccine
    39. BELL F; HEATH P; SHACKLEY F; MACLENNAN J; SHEARSTONE N; DIGGLE L; GRIFFITHS H; MOXON ER; FINN A
      EFFECT OF COMBINATION WITH AN ACELLULAR PERTUSSIS, DIPHTHERIA, TETANUS VACCINE ON ANTIBODY-RESPONSE TO HIB VACCINE (PRP-T)

      Vaccine
    40. HALL E; PARTON R; WARDLAW AC
      RESPONSES TO ACELLULAR PERTUSSIS VACCINES AND COMPONENT ANTIGENS IN ACOUGHING-RAT MODEL OF PERTUSSIS

      Vaccine
    41. MINH NNT; EDELMAN K; HE Q; VILJANEN MK; ARVILOMMI H; MERTSOLA J
      ANTIBODY AND CELL-MEDIATED IMMUNE-RESPONSES TO BOOSTER IMMUNIZATION WITH A NEW ACELLULAR PERTUSSIS-VACCINE IN SCHOOL-CHILDREN

      Vaccine
    42. REIS EC; JACOBSON RM; TARBELL S; WENIGER BG
      TAKING THE STING OUT OF SHOTS - CONTROL OF VACCINATION-ASSOCIATED PAIN AND ADVERSE REACTIONS

      Pediatric annals
    43. BRAUN MM; TERRACCIANO G; SALIVE ME; BLUMBERG DA; VERMEERDEBONDT PE; HEIJBEL H; EVANS G; PATRIARCA PA; ELLENBERG SS
      REPORT OF A US PUBLIC-HEALTH SERVICE WORKSHOP ON HYPOTONIC-HYPORESPONSIVE EPISODE (HHE) AFTER PERTUSSIS IMMUNIZATION

      Pediatrics (Evanston)
    44. CHERRY JD; HEININGER U; STEHR K; CHRISTENSON P
      THE EFFECT OF INVESTIGATOR COMPLIANCE (OBSERVER BIAS) ON CALCULATED EFFICACY IN A PERTUSSIS-VACCINE TRIAL

      Pediatrics (Evanston)
    45. HEININGER U; CHERRY JD; STEHR K; SCHMITTGROHE S; UBERALL M; LAUSSUCQ S; ECKHARDT T; MEYER M; GOMBEIN J
      COMPARATIVE EFFICACY OF THE LEDERLE TAKEDA ACELLULAR PERTUSSIS COMPONENT DTP (DTAP) VACCINE AND LEDERLE WHOLE-CELL COMPONENT DTP VACCINE INGERMAN CHILDREN AFTER HOUSEHOLD EXPOSURE/

      Pediatrics (Evanston)
    46. STEHR K; CHERRY JD; HEININGER U; SCHMITTGROHE S; UBERALL M; LAUSSUCQ S; ECKHARDT T; MEYER M; ENGELHARDT R; CHRISTENSON P
      A COMPARATIVE EFFICACY TRIAL IN GERMANY IN INFANTS WHO RECEIVED EITHER THE LEDERLE TAKEDA ACELLULAR PERTUSSIS COMPONENT DTP (DTAP) VACCINE,THE LEDERLE WHOLE-CELL COMPONENT DTP VACCINE, OR DT VACCINE/

      Pediatrics
    47. HEININGER U; RICHTER M
      RECURRENT HYPOTONIC-HYPORESPONSIVE EPISODES AFTER IMMUNIZATION WITH ADIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HIB COMPONENT VACCINE

      Monatsschrift fur Kinderheilkunde
    48. JUST M
      RECOMMENDATIONS FOR IMMUNIZATIONS AT ADOLESCENCE IN EUROPE

      Biologicals
    49. BEEKMANN SE; DOEBBELING BN
      FRONTIERS OF OCCUPATIONAL-HEALTH - NEW VACCINES, NEW PROPHYLACTIC REGIMENS, AND MANAGEMENT OF THE HIV-INFECTED WORKER

      Infectious disease clinics of North America
    50. PLOTKIN SA; CADOZ M
      ACELLULAR VACCINE EFFICACY TRIALS

      The Pediatric infectious disease journal
    51. LIESE JG; MESCHIEVITZ CK; HARZER E; FROESCHLE J; HOSBACH P; HOPPE JE; PORTER F; STOJANOV S; NIINIVAARA K; WALKER AM; BELOHRADSKY BH; ADISDUTSCHMANN B; BUSCHING U; BURK M; BARTELS R; BERGER S; BERGER W; BERGNER A; BINDER K; BITTMANN B; BORGMEYER A; BRAUN H; BREINER W; DAUBUISSON CC; DOMAY J; ENZEL U; ERDL R; GEMPP W; GLEY EO; GROSS J; GRUMBACH S; HADID D; HELM K; HOCHSCHAU L; HOLTORF MR; HULTZSCH W; JESSBERGER W; KERSTEN M; KNAPP G; KOPPENLEITNER R; KUENSTLER R; KUNZER W; KUSTERMANN W; KUPFERSCHMID C; LANDVOGT K; LANGER M; MANGELSDORFTAXIS R; MARX D; MATTERN H; MAYER S; MENSEBACHGEMPP M; MENZEL U; MOLLMANN W; MOSER R; MUHLSCHLEGEL M; NEUHAUS A; NETZEL B; OEFELEIN E; OESTERLE H; REINEKE E; REITER W; SANDBRINK H; SCHAIRER H; SCHEELE H; SCHLAUD I; SCHOPFER H; SCHRAUT S; SCHWERDTFEGER M; SIEGEL R; STECHELE V; STURMLINGER M; TEMPEL V; TICHMANN I; THIELEMANN P; TOPFNER B; ULLNER R; VALENTIN R; VOIGT G; VOMSTEIN M; WEIDINGER J; WEINANS G; WEISMULLER H; WENK K; WILD M; VONWILLMANN A; WINKLER G; WORNLE R; WOLF W
      EFFICACY OF A 2-COMPONENT ACELLULAR PERTUSSIS-VACCINE IN INFANTS

      The Pediatric infectious disease journal
    52. BLACK SB; SHINEFIELD HR; BERGEN R; HART C; KREMERS R; LAVETTER A; LEMESURIER J; MOROZUMI PA; RAY P; LEWIS EM; FIREMAN B; SCHWALBE J; HALLAM P; SHANDLING M; DEKKER C; GRANOFF DM; IZU A; PODDA A
      SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/

      The Pediatric infectious disease journal
    53. PETERS VB; MAYER LF; SPERBER KE
      CORRELATION OF IN-VITRO T-CELL AND B-CELL FUNCTION WITH RESPONSES TO CHILDHOOD VACCINES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Viral immunology
    54. PAGLIACCIA C; MANETTI R; RAPPUOLI R
      PERTACTIN ANTIGENS EXTRACTED FROM BORDETELLA-PERTUSSIS AND BORDETELLA-BRONCHISEPTICA DIFFER IN THE ISOELECTRIC POINT

      Archives of microbiology
    55. HALPERIN SA; BARRETO L; EASTWOOD BJ; MEDD L; GUASPARINI R; MILLS E
      SAFETY AND IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS DIPHTHERIA TETANUS VACCINE GIVEN AS A SINGLE INJECTION WITH HAEMOPHILUS-INFLUENZAE-B CONJUGATE VACCINE

      Vaccine
    56. LIN TY; CHIANG BL
      SPECIFIC IMMUNE-RESPONSE IN ADULT MEDICAL PERSONNEL IMMUNIZED WITH ACELLULAR PERTUSSIS-VACCINE WITH SPECIAL EMPHASIS ON T-HELPER CELL RESPONSE

      Vaccine
    57. TOMODA T; OGURA H; KURASHIGE T
      2 PRIMARY DOSES OF DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIA VACCINE INDUCE IMMUNOLOGICAL RESPONSES TO BORDETELLA-PERTUSSIS AS STRONG AS THOSEINDUCED BY 3 PRIMARY DOSES

      Vaccine
    58. DEMARTINO M; PODDA A; GALLI L; SINANGIL F; MANNELLI F; ROSSI ME; VIERUCCI A
      ACELLULAR PERTUSSIS-VACCINE IN CHILDREN WITH PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS-TYPE-1 INFECTION

      Vaccine
    59. GRANSTROM M; TINDBERG Y; BLENNOW M
      SEROEPIDEMIOLOGY OF HELICOBACTER-PYLORI INFECTION IN A COHORT OF CHILDREN MONITORED FROM 6 MONTHS TO 11 YEARS OF AGE

      Journal of clinical microbiology
    60. STEHR K; HEININGER U; UHLENBUSCH R; ANGERSBACH P; HACKELL J; ECKHARDT T
      IMMUNOGENICITY AND REACTOGENICITY OF AN A CELLULAR, MONOVALENT 4-COMPONENT PERTUSSIS-VACCINE AS A BOOSTER DOSE IN PRESCHOOL AND EARLY SCHOOL-AGE-CHILDREN

      Monatsschrift fur Kinderheilkunde
    61. OTTO T; BEX A; KREGE S; WALZ PH; RUBBEN H
      PACLITAXEL-BASED 2ND-LINE THERAPY FOR PATIENTS WITH ADVANCED CHEMOTHERAPY-RESISTANT BLADDER-CARCINOMA (M1) - A CLINICAL-PHASE-II STUDY

      Cancer
    62. GALAZKA AM; ROBERTSON SE
      IMMUNIZATION AGAINST DIPHTHERIA WITH SPECIAL EMPHASIS ON IMMUNIZATIONOF ADULTS

      Vaccine
    63. HUANG LM; LEE CY; LIN TY; CHEN JM; LEE PI; HSU CY
      RESPONSES TO PRIMARY AND A BOOSTER DOSE OF ACELLULAR, COMPONENT, AND WHOLE-CELL PERTUSSIS VACCINES INITIATED AT 2 MONTHS OF AGE

      Vaccine
    64. HALPERIN SA; EASTWOOD BJ; BARRETO L; FRIESEN B; MEDD L; MEEKISON W; GUASPARINI R
      ADVERSE REACTIONS AND ANTIBODY-RESPONSE TO 4 DOSES OF ACELLULAR OR WHOLE-CELL PERTUSSIS-VACCINE COMBINED WITH DIPHTHERIA AND TETANUS TOXOIDS IN THE FIRST 19 MONTHS OF LIFE

      Vaccine
    65. LIVOLTI S; MATTINA T; MAURO L; ANFUSO S; URSINO A; MOLLICA F
      SAFETY AND EFFECTIVENESS OF AN ACELLULAR PERTUSSIS-VACCINE IN SUBJECTS WITH DOWNS-SYNDROME

      Child's nervous system
    66. ROTHSTEIN EP; KAMIYA H; NII R; MATSUDA T; BERNSTEIN HH; LONG SS; HOSBACH PH; MESCHIEVITZ CK
      COMPARISON OF DIPHTHERIA-TETANUS-2 COMPONENT ACELLULAR PERTUSSIS VACCINES IN UNITED-STATES AND JAPANESE INFANTS AT 2, 4, AND 6 MONTHS OF AGE

      Pediatrics
    67. HALPERIN SA; MILLS E; BARRETO L; PIM C; EASTWOOD BJ
      ACELLULAR PERTUSSIS-VACCINE AS A BOOSTER DOSE FOR 17-MONTH-OLD TO 19-MONTH-OLD CHILDREN IMMUNIZED WITH EITHER WHOLE-CELL OR ACELLULAR PERTUSSIS-VACCINE AT 2, 4 AND 6 MONTHS OF AGE

      The Pediatric infectious disease journal
    68. GERSHON AA
      PRESENT AND FUTURE CHALLENGES OF IMMUNIZATIONS ON THE HEALTH OF OUR PATIENTS

      The Pediatric infectious disease journal
    69. STEHR K; HEININGER U; UHLENBUSCH R; ANGERSBACH P; HACKELL J; ECKHARDT T; BAHRINIPOUR M; FALKENBERG N; HARMS E; HOPFNER J; KALUZA D; LUBBEN U; LUDWIG M; MICHAELIS E; RUGGEBERG F; SCHOTOLA H; STEINBERG H; VEHSE H; WOLSCHNER H
      IMMUNOGENICITY AND SAFETY OF A MONOVALENT, MULTICOMPONENT ACELLULAR PERTUSSIS-VACCINE IN 15-MONTH 6-YEAR-OLD GERMAN CHILDREN

      European journal of pediatrics
    70. JONES DH; MCBRIDE BW; JEFFERY H; OHAGAN DT; ROBINSON A; FARRAR GH
      PROTECTION OF MICE FROM BORDETELLA-PERTUSSIS RESPIRATORY-INFECTION USING MICROENCAPSULATED PERTUSSIS FIMBRIAE

      Vaccine
    71. BERNSTEIN HH; ROTHSTEIN EP; PICHICHERO ME; GREEN JL; REISINGER KS; BLATTER MM; HALPERN J; ARBETER AM; BERNSTEIN DI; SMITH V; LONG SS; RATHFON H; KRAUSE DS
      REACTOGENICITY AND IMMUNOGENICITY OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE ADMINISTERED AS THE PRIMARY SERIES TO 2, 4 AND 6 MONTH OLD INFANTS IN THE UNITED-STATES

      Vaccine
    72. BASS JW; WITTLER RR
      RETURN OF EPIDEMIC PERTUSSIS IN THE UNITED-STATES

      The Pediatric infectious disease journal
    73. RAPPUOLI R
      TOXIN INACTIVATION AND ANTIGEN STABILIZATION - 2 DIFFERENT USES OF FORMALDEHYDE

      Vaccine
    74. VANURA H; JUST M; AMBROSCH F; BERGER RM; BOGAERTS H; WYNEN J; VANDEVOORDE D; WIEDERMANN G
      STUDY OF PERTUSSIS VACCINES IN INFANTS - COMPARISON OF RESPONSE TO ACELLULAR PERTUSSIS DTP VACCINES CONTAINING 25 MU-G OF FHA AND EITHER 25OR 8 MU-G OF PT WITH RESPONSE TO WHOLE-CELL PERTUSSIS DTP VACCINE

      Vaccine
    75. ANDERSON EL; MINK CM; BERLIN BS; SHIH CN; TUNG FF; BELSHE RB
      ACELLULAR PERTUSSIS VACCINES IN INFANTS - EVALUATION OF SINGLE-COMPONENT AND 2-COMPONENT PRODUCTS

      Vaccine
    76. HEININGER U; CHERRY JD; CHRISTENSON PD; ECKHARDT T; GOERING U; JAKOB P; KASPER W; SCHWEINGEL D; LAUSSUCQ S; HACKELL JG; MEZZATESTA JR; SCOTT JV; STEHR K
      COMPARATIVE-STUDY OF LEDERLE TAKEDA ACELLULAR AND LEDERLE WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS IN GERMANY

      Vaccine
    77. BERNSTEIN HH; ROTHSTEIN EP; REISINGER KS; BLATTER MM; ARBETER AM; FONTANA ME; JACOBS JM; LONG SS; RATHFON H; CRAYNE O; KRAUSE DS; SCHILLER RP; GIRONE JAC; HIPP TJ; SOUDER RL; KENNEDY TI; FACCENDA DR
      COMPARISON OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE WITH A WHOLE-CELL PERTUSSIS-VACCINE IN 15-MONTH-OLD THROUGH 20-MONTH-OLD INFANTS

      Pediatrics
    78. ENGLUND JA; DECKER MD; EDWARDS KM; PICHICHERO ME; STEINHOFF MC; ANDERSON EL
      ACELLULAR AND WHOLE-CELL PERTUSSIS VACCINES AS BOOSTER DOSES - A MULTICENTER STUDY

      Pediatrics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 00:31:04